Gallagher Capital Advisors LLC Acquires New Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Gallagher Capital Advisors LLC bought a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm bought 5,154 shares of the medical equipment provider’s stock, valued at approximately $2,690,000. Intuitive Surgical accounts for 2.0% of Gallagher Capital Advisors LLC’s portfolio, making the stock its 19th biggest position.

Several other institutional investors also recently bought and sold shares of ISRG. Moran Wealth Management LLC boosted its stake in shares of Intuitive Surgical by 1.7% in the fourth quarter. Moran Wealth Management LLC now owns 1,778 shares of the medical equipment provider’s stock valued at $928,000 after purchasing an additional 29 shares during the period. Main Street Research LLC lifted its holdings in Intuitive Surgical by 1.9% during the 4th quarter. Main Street Research LLC now owns 79,531 shares of the medical equipment provider’s stock worth $41,512,000 after buying an additional 1,482 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank boosted its position in Intuitive Surgical by 24.5% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 187,398 shares of the medical equipment provider’s stock valued at $97,814,000 after buying an additional 36,865 shares during the period. NBT Bank N A NY increased its position in shares of Intuitive Surgical by 28.0% during the fourth quarter. NBT Bank N A NY now owns 2,489 shares of the medical equipment provider’s stock worth $1,299,000 after acquiring an additional 544 shares during the period. Finally, Taika Capital LP purchased a new stake in shares of Intuitive Surgical during the fourth quarter worth $4,685,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other Intuitive Surgical news, CFO Jamie Samath sold 94 shares of Intuitive Surgical stock in a transaction on Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total value of $53,684.34. Following the transaction, the chief financial officer now directly owns 2,630 shares in the company, valued at approximately $1,502,019.30. The trade was a 3.45 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Amal M. Johnson sold 4,635 shares of the stock in a transaction dated Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the sale, the director now owns 12,275 shares of the company’s stock, valued at $6,955,015. This trade represents a 27.41 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 13,579 shares of company stock valued at $7,756,844. 0.90% of the stock is currently owned by company insiders.

Intuitive Surgical Stock Down 3.8 %

Shares of NASDAQ ISRG opened at $518.26 on Monday. The stock has a market cap of $184.59 billion, a PE ratio of 80.85, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43. Intuitive Surgical, Inc. has a 52-week low of $364.17 and a 52-week high of $616.00. The business has a 50-day moving average price of $571.36 and a 200 day moving average price of $531.85.

Analyst Upgrades and Downgrades

Several research analysts recently commented on ISRG shares. Erste Group Bank raised Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Tuesday, November 19th. Raymond James lifted their price target on shares of Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a research note on Friday, January 24th. Jefferies Financial Group boosted their price target on shares of Intuitive Surgical from $475.00 to $575.00 in a report on Monday, January 27th. Evercore ISI raised their price objective on shares of Intuitive Surgical from $490.00 to $530.00 in a report on Monday, January 27th. Finally, Bernstein Bank boosted their target price on shares of Intuitive Surgical from $655.00 to $700.00 and gave the stock an “overweight” rating in a research note on Monday, January 27th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and sixteen have issued a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $613.10.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.